Share on StockTwits

Acceleron Pharma (NASDAQ:XLRN) VP Ravindra Kumar sold 7,000 shares of the company’s stock in a transaction dated Friday, June 20th. The stock was sold at an average price of $35.00, for a total value of $245,000.00. Following the completion of the transaction, the vice president now directly owns 37,890 shares of the company’s stock, valued at approximately $1,326,150. The sale was disclosed in a document filed with the SEC, which is available at this link.

Shares of Acceleron Pharma (NASDAQ:XLRN) traded down 3.21% during mid-day trading on Tuesday, hitting $33.50. The stock had a trading volume of 189,861 shares. Acceleron Pharma has a 52-week low of $16.78 and a 52-week high of $57.89. The stock has a 50-day moving average of $32.03 and a 200-day moving average of $38.3. The company’s market cap is $1.054 billion.

Acceleron Pharma (NASDAQ:XLRN) last released its earnings data on Thursday, May 15th. The company reported ($0.30) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.44) by $0.14. The company had revenue of $3.31 million for the quarter, compared to the consensus estimate of $2.85 million. Analysts expect that Acceleron Pharma will post $-1.24 EPS for the current fiscal year.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.